Athira Pharma Inc
For the period ended May 23, 2024. Filed Apr 9, 2024.
View on SEC.govAbout this filing
What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.
May 23, 2024 · Filed Apr 9, 2024
Contents
PROXY STATEMENT SUMMARY
Proxy Statement
Summary
Meeting Date:
May 23, 2024
Meeting Time:
8:00 a.m., Pacific Time
Meeting Location:
The Annual Meeting will be conducted virtually via live audio webcast. You will be able to attend the Annual Meeting virtually by visiting www. virtualshareholder meeting.com/ ATHA2024, where you will be able to listen to the meeting live, submit questions and vote online during the meeting.
VOTING MATTERS
| Proposal · · · · · Board Recommendation · · · Page Reference | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| 1 | | | To elect three Class I directors of the Company, each to serve for a term of three years and until his or her respective successor is elected and qualified, or until his or her earlier death, resignation or removal. | | | “FOR” the election of each Class I director nominee named | | | 25 |
| 2 | | | To ratify the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for its fiscal year ending December 31, 2024. | | | “FOR” the ratification of the appointment of Ernst & Young LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2024 | | | 26 |
| 3 | | | To approve an amendment to the Company’s amended and restated certificate of incorporation to limit the liability of officers as permitted by Delaware law. | | | “FOR” an amendment to the Company’s amended and restated certificate of incorporation to limit the liability of officers as permitted by Delaware law | | | 29 |
| 4 | | | To vote on any other matters that may properly come before the Annual Meeting. | | | — | | | — |
The Notice of Internet Availability of Proxy Materials, or Notice of Internet Availability, containing instructions on how to access this proxy statement, the accompanying notice of annual meeting and form of proxy, and our annual report, is first being sent or given on or about April 9, 2024 to all stockholders of record as of March 26, 2024.
| Athira Pharma, Inc. | | | 1 | | | 2024 Proxy Statement |
|---|
PROXY STATEMENT
To be Held at 8:00 a.m., Pacific Time, on May 23, 2024
The board of directors of Athira Pharma, Inc., a Delaware corporation (“we,” “us,” “our,” the “Company” or “Athira”), is soliciting proxies to be used at our 2024 annual meeting of stockholders (together with any postponement, adjournment or continuation thereof, the “Annual Meeting”). The Annual Meeting will be held on May 23, 2024, at 8:00 a.m., Pacific Time. The Annual Meeting will be conducted virtually via live audio webcast. You will be able to attend the Annual Meeting virtually by visiting www.virtualshareholdermeeting.com/ATHA2024, where you will be able to listen to the meeting live, submit questions and vote online during the meeting.
The Notice of Internet Availability of Proxy Materials, or Notice of Internet Availability, containing instructions on how to access this proxy statement, the accompanying notice of annual meeting and form of proxy, and our annual report, is first being sent or given on or about April 9, 2024 to all stockholders of record as of March 26, 2024. The proxy materials and our annual report can be accessed as of April 9, 2024 by visiting www.proxyvote.com. If you receive a Notice of Internet Availability, then you will not receive a printed copy of the proxy materials or our annual report in the mail unless you specifically request these materials. Instructions for requesting a printed copy of the proxy materials and our annual report are set forth in the Notice of Internet Availability.
The information provided in the “question and answer” format below is for your convenience only and is merely a summary of the information contained in this proxy statement. You should read this entire proxy statement carefully.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.